EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Potential of Cytoglobin and Neuroglobin in Oxidative Stress-Driven Liver Diseases

Le Thi Thanh Thuy iD, Hoang Hai, Pham Tuan Anh, Nguyen Bui Tam Chi, Tran Van Bao iD, Tran Dang Anh Huyen iD, Nguyen Tran Quang Sang, Michelle L Hermiston iD

Antioxidants · 14.04.2026 · 15 (4) · 485

DOI: 10.3390/antiox15040485 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 14.04.2026. Verfasst von Le Thi Thanh Thuy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Education and Medical Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vinmec Healthcare System Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic liver diseases, including fibrosis and hepatocellular carcinoma (HCC), are primarily driven by oxidative stress, yet traditional antioxidant therapies often lack the specificity and efficacy required for clinical success. This review evaluates the emerging therapeutic potential of two atypical globins, cytoglobin (CYGB) and neuroglobin (NGB), exploring their unique hexacoordinated heme structures that enable potent reactive oxygen and nitrogen species (ROS/RNS) scavenging and redox-regulated signaling. We summarize a broad range of in vitro and in vivo evidence demonstrating that these globins deactivate hepatic stellate cells, reduce extracellular matrix accumulation, and function as tumor suppressors by modulating pathways such as Raf/MEK/ERK and NRF2. In human cohorts, CYGB expression levels inversely correlate with the progression of Metabolic Dysfunction-Associated Steatohepatitis (MASH) and HCC, highlighting its potential as a clinical biomarker. Furthermore, recombinant protein therapies involving CYGB and NGB show promise in promoting collagen degradation and inhibiting malignant transformation. We conclude that CYGB and NGB represent sophisticated catalytic redox regulators that offer a novel therapeutic paradigm for restoring redox homeostasis. While delivery and pharmacokinetic barriers remain, these globins are highly promising candidates for first-in-class biologics in hepatology.

Schlagwörter

Stichwörter der Autor:innen

antioxidantglobinliver cancerliver fibrosis

Autor:innen und Institutionen

  • Department of Global Education and Medical Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
  • Sarcoma Center, Vinmec Times City International Hospital, Vinmec Healthcare System, Hanoi 11622, Vietnam.
  • Center for Innovation in Health Sciences, College of Health Sciences, VinUniversity, Hanoi 12400, Vietnam.

ORCID-Profile: Le Thi Thanh Thuy, Tran Van Bao, Tran Dang Anh Huyen, Michelle L Hermiston

Förderung

  • Vinmec Healthcare System Research Fund

Zitieren

APA

Thuy, L. T. T., Hai, H., Anh, P. T., Chi, N. B. T., Bao, T. V., Huyen, T. D. A., Sang, N. T. Q., & Hermiston, M. L. (2026). Therapeutic Potential of Cytoglobin and Neuroglobin in Oxidative Stress-Driven Liver Diseases. Antioxidants, 15(4), 485. https://doi.org/10.3390/antiox15040485

Vancouver

Thuy LTT, Hai H, Anh PT, Chi NBT, Bao TV, Huyen TDA, et al. Therapeutic Potential of Cytoglobin and Neuroglobin in Oxidative Stress-Driven Liver Diseases. Antioxidants. 2026;15(4):485. doi:10.3390/antiox15040485

BibTeX
@article{Thuy2026,
  author = {Thuy, Le Thi Thanh and Hai, Hoang and Anh, Pham Tuan and Chi, Nguyen Bui Tam and Bao, Tran Van and Huyen, Tran Dang Anh and Sang, Nguyen Tran Quang and Hermiston, Michelle L},
  title = {Therapeutic Potential of Cytoglobin and Neuroglobin in Oxidative Stress-Driven Liver Diseases},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {485},
  doi = {10.3390/antiox15040485}
}
Kostenlos starten →